Showing results (171-180 of 462) with videos related to

Sort By:
Pageof 47
Central Nervous System Agents in Medicinal Chemistry|February 27, 2016
Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary InterventionYamel Rito, Ivan Torre-Villalvazo, Jose Flores, et al.
Central Nervous System Agents in Medicinal Chemistry|August 5, 2015
Innovative Anthocyanin/Anthocyanidin Formulation Protects SK-N-SH Cells Against the Amyloid-β Peptide-Induced Toxicity: Relevance to Alzheimer's DiseaseAbdenour Belkacemi, Charles Ramassamy
Central Nervous System Agents in Medicinal Chemistry|December 27, 2014
Regulation of dopamine signaling in the striatum by phosphodiesterase inhibitors: novel therapeutics to treat neurological and psychiatric disordersAndres D Ramirez, Sean M Smith
Central Nervous System Agents in Medicinal Chemistry|November 5, 2015
Targeting Dopaminergic System for Treating Nicotine DependenceSawsan Abuhamdah, Ashraf Khalil, Youssef Sari
Central Nervous System Agents in Medicinal Chemistry|April 27, 2018
Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-MethyltransferaseIdalet Engelbrecht, Jacobus P Petzer, Anel Petzer
Central Nervous System Agents in Medicinal Chemistry|August 18, 2018
Human Suicide Risk and Treatment StudyDa-Yong Lu, Peng-Peng Zhu, Hong-Ying Wu, et al.
Central Nervous System Agents in Medicinal Chemistry|August 14, 2018
Brain and Quantum Dots: Benefits of Nanotechnology for Healthy and Diseased BrainYuri N Utkin
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitorsYiquan Chen, Vincent Meininger, Gilles J Guillemin
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
New antiepileptic drugs: molecular targetsMarco Mula
Central Nervous System Agents in Medicinal Chemistry|December 22, 2009
Histamine H3-receptor inverse agonists as novel antipsychoticsChihiro Ito
Pageof 47